tiprankstipranks
BeiGene announces proposed name change to ‘BeOne Medicines’
PremiumThe FlyBeiGene announces proposed name change to ‘BeOne Medicines’
9d ago
BeiGene price target raised to $260 from $254 at TD Cowen
Premium
The Fly
BeiGene price target raised to $260 from $254 at TD Cowen
10d ago
BeiGene Ltd. Releases Quarterly Report Update
Premium
Company Announcements
BeiGene Ltd. Releases Quarterly Report Update
11d ago
BeiGene Announces Board Changes After Director’s Passing
PremiumCompany AnnouncementsBeiGene Announces Board Changes After Director’s Passing
26d ago
BeiGene Ltd. Announces New Board Composition
Premium
Company Announcements
BeiGene Ltd. Announces New Board Composition
26d ago
Indaptus Therapeutics announces clinical supply agreement with BeiGene
Premium
The Fly
Indaptus Therapeutics announces clinical supply agreement with BeiGene
1M ago
BeiGene Ltd. Announces SEC Filing Compliance
PremiumCompany AnnouncementsBeiGene Ltd. Announces SEC Filing Compliance
2M ago
BeiGene Announces Board and Committee Structure
Premium
Company Announcements
BeiGene Announces Board and Committee Structure
2M ago
BeiGene says FDA’s ODAC sees favorable benefit-risk profile of PD-1 inhibitors
Premium
The Fly
BeiGene says FDA’s ODAC sees favorable benefit-risk profile of PD-1 inhibitors
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100